Bayo, Mariflor M.

HRN: 23-72-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
CEFTRIAXONE 1G (VIAL)
09/21/2023
09/27/2023
IV
2g
Q24
Acute Pyelonephritis; R/O Typhoid Fever
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: